HOME > ARCHIVE
ARCHIVE
- Astellas Pharma Approves New 5-Year Management Plan
October 16, 2006
- Nipro Aims to Boost Sales of Generics to \20 Bil. by 2010
October 16, 2006
- NEW PRODUCTS Alcon Japan, Kyowa Hakko: PATANOL Ophthalmic Solution 0.1%
October 16, 2006
- GENERICS NEWS IN BRIEF Court Rules for Central Glass, Abbott Laboratories in Patent Infringement Case
October 16, 2006
- Partnerships and Alliances Key to Improving R&D Productivity: Pfizer
October 16, 2006
- MEDICAL DEVICE NEWS IN BRIEF
October 16, 2006
- IFPW's 2006 General Membership Meeting in San Francisco
October 16, 2006
- NEW PRODUCTS Kainos to Launch ADAMTS13 Research Reagent
October 16, 2006
- Frictions Escalate between JPA and NPhA
October 16, 2006
- Drug Cost Ratio Rose 0.5 Points to 22.1% in FY2005
October 16, 2006
- BUSINESS NEWS IN BRIEF
October 16, 2006
- Debiopharm Enhances Its Presence in Japan
October 16, 2006
- Clinical Trial Study Group Discusses Way to Lighten Sponsors' Burden
October 9, 2006
- CMIC Begins CRF Checking Services
October 9, 2006
- PMDA to More Closely Cooperate with Other Asian Countries: Mr Miyajima
October 9, 2006
- FTC Survey Faults New Drug Makers for Misleading Info. on Generics
October 9, 2006
- R&D NEWS IN BRIEF
October 9, 2006
- Expert Sees Legal Risk in Limited-Facility, All-case PMS
October 9, 2006
- MEDICAL DEVICE NEWS IN BRIEF
October 9, 2006
- Pros and Cons of All-Case PMS Presented: SJP Seminar
October 9, 2006
ページ
In the complex landscape of the Japanese pharmaceutical market, the “status quo” is often the safest harbor. But for leaders like Kennet Brysting, former president of Gilead Japan, the status quo is the most dangerous place to stay.Innovation in Japan…
